204 related articles for article (PubMed ID: 29680587)
1. Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation.
Vos M; Plasmeijer EI; van Bemmel BC; van der Bij W; Klaver NS; Erasmus ME; de Bock GH; Verschuuren EAM; Rácz E
J Heart Lung Transplant; 2018 Jul; 37(7):853-859. PubMed ID: 29680587
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous squamous cell carcinoma (cSCC) and immunosurveillance - the impact of immunosuppression on frequency of cSCC.
Plasmeijer EI; Sachse MM; Gebhardt C; Geusau A; Bouwes Bavinck JN
J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():33-37. PubMed ID: 31833604
[TBL] [Abstract][Full Text] [Related]
4. Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients?
Johnson DW; Nicol DL; Purdie DM; Preston JM; Brown AM; Hawley CM; Campbell SB; Wall D; Griffin AD; Isbel NM
Transplantation; 2002 Apr; 73(7):1158-63. PubMed ID: 11965051
[TBL] [Abstract][Full Text] [Related]
5. Cohort and nested case-control study of cutaneous squamous cell carcinoma in solid organ transplant recipients, by medication.
Dusendang JR; Carlson E; Lee DS; Marwaha S; Madani S; Alexeeff SE; Webber A; Goes NB; Herrinton LJ
J Am Acad Dermatol; 2022 Mar; 86(3):598-606. PubMed ID: 34384835
[TBL] [Abstract][Full Text] [Related]
6. High azathioprine dose and lip cancer risk in liver, heart, and lung transplant recipients: A population-based cohort study.
Na R; Laaksonen MA; Grulich AE; Meagher NS; McCaughan GW; Keogh AM; Vajdic CM
J Am Acad Dermatol; 2016 Jun; 74(6):1144-1152.e6. PubMed ID: 26830865
[TBL] [Abstract][Full Text] [Related]
7. Increased incidence of squamous cell carcinoma of the skin after long-term treatment with azathioprine in patients with auto-immune inflammatory rheumatic diseases.
van den Reek JM; van Lümig PP; Janssen M; Schers HJ; Hendriks JC; van de Kerkhof PC; Seyger MM; de Jong EM
J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):27-33. PubMed ID: 23216663
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.
Remuzzi G; Cravedi P; Costantini M; Lesti M; Ganeva M; Gherardi G; Ene-Iordache B; Gotti E; Donati D; Salvadori M; Sandrini S; Segoloni G; Federico S; Rigotti P; Sparacino V; Ruggenenti P
J Am Soc Nephrol; 2007 Jun; 18(6):1973-85. PubMed ID: 17460145
[TBL] [Abstract][Full Text] [Related]
9. Malignancy After Heart Transplantation Under Everolimus Versus Mycophenolate Mofetil Immunosuppression.
Wang YJ; Chi NH; Chou NK; Huang SC; Wang CH; Wu IH; Yu HY; Chen YS; Tsao CI; Shun CT; Tsai JT; Wang SS
Transplant Proc; 2016 Apr; 48(3):969-73. PubMed ID: 27234781
[TBL] [Abstract][Full Text] [Related]
10. Malignancies after heart transplantation: incidence, risk factors, and effects of calcineurin inhibitor withdrawal.
Doesch AO; Müller S; Konstandin M; Celik S; Kristen A; Frankenstein L; Ehlermann P; Sack FU; Katus HA; Dengler TJ
Transplant Proc; 2010 Nov; 42(9):3694-9. PubMed ID: 21094840
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil in pancreas transplantation.
Gruessner RW; Sutherland DE; Drangstveit MB; Wrenshall L; Humar A; Gruessner AC
Transplantation; 1998 Aug; 66(3):318-23. PubMed ID: 9721799
[TBL] [Abstract][Full Text] [Related]
12. The effect of mycophenolate mofetil and azathioprine dose on renal allograft outcome in the United kingdom.
Shah S; Collett D; Johnson R; Raftery M; Rudge C; Yaqoob MM
Transplantation; 2008 Oct; 86(8):1035-42. PubMed ID: 18946340
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation.
O'Neill JO; Edwards LB; Taylor DO
J Heart Lung Transplant; 2006 Oct; 25(10):1186-91. PubMed ID: 17045930
[TBL] [Abstract][Full Text] [Related]
14. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
[TBL] [Abstract][Full Text] [Related]
15. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
Thierry A; Le Meur Y; Ecotière L; Abou-Ayache R; Etienne I; Laurent C; Vuiblet V; Colosio C; Bouvier N; Aldigier JC; Rerolle JP; Javaugue V; Gand E; Bridoux F; Essig M; Hurault de Ligny B; Touchard G
Transpl Int; 2016 Jan; 29(1):23-33. PubMed ID: 26729582
[TBL] [Abstract][Full Text] [Related]
16. Impact of de novo everolimus-based immunosuppression on incisional complications in heart transplantation.
Zuckermann A; Arizon JM; Dong G; Eisen HJ; Kobashigawa J; Lehmkuhl H; Ross H; Pelligrini C; Wang SS; Barten MJ
Transplantation; 2011 Sep; 92(5):594-600. PubMed ID: 21862955
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of azathioprine versus mycophenolate mofetil in cyclosporine-based immunosuppression in kidney transplantation: 10 years of experience at a single center.
Kwon O; Cho JH; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
Transplant Proc; 2013 May; 45(4):1487-90. PubMed ID: 23726603
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience.
Ross DJ; Waters PF; Levine M; Kramer M; Ruzevich S; Kass RM
J Heart Lung Transplant; 1998 Aug; 17(8):768-74. PubMed ID: 9730425
[TBL] [Abstract][Full Text] [Related]
19. The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis.
Kosmidis C; Mackenzie A; Harris C; Hashad R; Lynch F; Denning DW
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2233-2237. PubMed ID: 32820348
[TBL] [Abstract][Full Text] [Related]
20. Ten-Year Follow-up of Persons With Sun-Damaged Skin Associated With Subsequent Development of Cutaneous Squamous Cell Carcinoma.
Madani S; Marwaha S; Dusendang JR; Alexeeff S; Pham N; Chen EH; Han S; Herrinton LJ
JAMA Dermatol; 2021 May; 157(5):559-565. PubMed ID: 33760003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
